Shanxi C&Y Pharmaceutical Group Co (SZSE:300254) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SZSE:300254 Shanxi C&Y Pharmaceutical Group Co Ltd SZSE:300254
47 GF Score
Price ¥9.25
GF Value ¥12.40
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Shanxi C&Y Pharmaceutical Group Co FFO?

FFO (Funds from operations) only applies to REITs.

SZSE:300254
47GF Score
Shanxi C&Y Pharmaceutical Group Co Ltd SZSE:300254
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Shanxi C&Y Pharmaceutical Group Co (SZSE:300254) Overvalued in 2026?

Based on GuruFocus' analysis, Shanxi C&Y Pharmaceutical Group Co stock appears to be undervalued. The current stock price of ¥9.25 is trading 25.4% below its estimated GF Value™ of ¥12.40. GuruFocus considers Shanxi C&Y Pharmaceutical Group Co to be Modestly Undervalued.

Key valuation signals for SZSE:300254:

  • FFO:
  • GF Value™: ¥12.40 vs. price of ¥9.25 (25.4% below fair value)
  • GF Score™: 47/100 with 6 warning signs

No single metric tells the full story. See the SZSE:300254 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanxi C&Y Pharmaceutical Group Co Business Description

Address No.53, Hubin Street, Economic and Technological Development Zone, Datong, CHN, 037010
Shanxi C&Y Pharmaceutical Group Co Ltd is engaged in the production, research and development, and sales of pharmaceutical products. The company offers pregnancy products and services, anti-infective, and urinary health.
47GF Score

Get the complete analysis for SZSE:300254

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥9.25
Price
¥12.40
GF Value